Open Innovation

Through 'Open Innovation', Precision Biosensor is collaborating with global companies and
research institutes with various biomarkers to jointly develop and commercialize novel
and competitive diagnostic items on our TRF Platform.

We are providing POCT commercialization solutions through our TRF Platform with higher sensitivity and
accuracy compared to the existing LFA through our fully integrated business structure.
  • Biomarker
  • Feasibility Test
  • Clinical Trial
  • Certification
  • New Product
  • Biomarker
  • Feasibility Test
  • Clinical Trial
  • Certification
  • New Product
New
Biomarker
New
Biomarker
New
Biomarker
New
Biomarker
New
Biomarker
New
Biomarker
Partnering
Precision Biosensor is collaborating with global NGOs, diagnostic companies and research institutes at home and abroad to develop high-sensitivity POCT products.
  • 2019
    TRF Cartridge co-development for CRE diagnosis
  • TRF Cartridge co-development for brain diseases diagnosis
  • TRF Cartridge co-development for norovirus diagnosis
  • ODM business development for Gold Analyzers
  • 2017
    TRF Cartridge co-development for tuberculosis diagnosis
  • 2016
    Development and distribution of residues of antibiotics analyzers
  • 2015
    Development and distribution of colorimetric absorption analyzers
  • 2014
    HIV, HBV, HCV antigen development & technology transfer
  • 2006
    Co-development for micro-fluidic channels TnI Cartridge
  • 2005
    Co-development for lab on a chip technology
  • 2002
    Co-development for bovine pregnancy biomarker